Published in J Cardiovasc Pharmacol on January 01, 1988
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. CMAJ (1993) 1.68
Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies. Postgrad Med J (1999) 1.38
Testing of serum atherogenicity in cell cultures: questionable data published. Ger Med Sci (2012) 0.89
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil. Drugs (1992) 0.79
Soy and phytoestrogens: possible side effects. Ger Med Sci (2014) 0.77
Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50
The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics (1994) 4.04
Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol (1993) 3.76
In vitro propagation of the prion-like state of yeast Sup35 protein. Science (1997) 3.05
Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene (1988) 2.12
Isolation and characterization of actin-like protein from yeast Saccharomyces cerevisiae. FEBS Lett (1979) 2.06
Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol (2000) 1.96
Divergence and conservation of SUP2 (SUP35) gene of yeast Pichia pinus and Saccharomyces cerevisiae. Yeast (1991) 1.72
Red pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1967) 1.67
Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol Cell Biol (1997) 1.61
Ribosome-bound EF-1 alpha-like protein of yeast Saccharomyces cerevisiae. Eur J Biochem (1991) 1.49
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
Mechano-chemical control of human endothelium orientation and size. J Cell Biol (1989) 1.33
Recessive super-suppression in yeast. Mol Gen Genet (1974) 1.29
Studies of energy transport in heart cells. Mitochondrial isoenzyme of creatine phosphokinase: kinetic properties and regulatory action of Mg2+ ions. Eur J Biochem (1975) 1.28
C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet (1998) 1.26
Recessive nonsense-suppression in yeast: further characterization of a defect in translation. FEBS Lett (1976) 1.24
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
[Psi(+)] prion generation in yeast: characterization of the 'strain' difference. Yeast (2001) 1.15
Role of creatine phosphokinase in cellular function and metabolism. Can J Physiol Pharmacol (1978) 1.09
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis (1986) 1.04
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Studies of energy transport in heart cells. The functional coupling between mitochondrial creatine phosphokinase and ATP ADP translocase: kinetic evidence. Arch Biochem Biophys (1976) 1.02
Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) (2002) 1.01
Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies. Biochim Biophys Acta (1984) 1.00
A study of the structure of fibronectin. Eur J Biochem (1981) 1.00
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Calcium-binding rate and capacity of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol (1981) 1.00
Itt1p, a novel protein inhibiting translation termination in Saccharomyces cerevisiae. BMC Mol Biol (2001) 0.98
Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. J Appl Physiol (1985) (1988) 0.97
Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc Natl Acad Sci U S A (1981) 0.96
Heterogeneity of endothelium in human aorta. A quantitative analysis by scanning electron microscopy. Atherosclerosis (1984) 0.96
Recessive nonsense-suppression in yeast: involvement of 60S ribosomal subunit. Mol Gen Genet (1978) 0.95
Ribosomal recessive suppressors cause a respiratory deficiency in yeast Saccharomyces cerevisiae. Mol Gen Genet (1982) 0.94
Kinetic properties and the functional role of particulate MM-isoenzyme of creatine phosphokinase bound to heart muscle myofibrils. FEBS Lett (1976) 0.94
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis (1991) 0.93
Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Mosc) (2002) 0.93
Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun (1989) 0.92
Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J Biol Chem (1982) 0.92
Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Arch (2000) 0.92
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells. Am J Cardiol (1987) 0.92
Centrosome injury in cells infected with human cytomegalovirus. J Struct Biol (1997) 0.91
Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun (1979) 0.91
Study of energy transport mechanism in myocardial cells. Circ Res (1974) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol (1992) 0.89
Dissociated cells from different layers of adult human aortic wall. Acta Anat (Basel) (1984) 0.89
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem (1992) 0.88
Direct anti-atherosclerosis-related effects of garlic. Ann Med (1995) 0.88
Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta (1986) 0.88
Synthesis of some hydroxynaphthazarins and their cardioprotective effects under ischemia-reperfusion in vivo. Bioorg Med Chem Lett (1998) 0.88
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
[Structure and functional similarity of yeast Sup35p and Ure2p proteins to mammalian prions]. Mol Biol (Mosk) (1995) 0.87
Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells. FEBS Lett (1987) 0.87
Translation termination factors function outside of translation: yeast eRF1 interacts with myosin light chain, Mlc1p, to effect cytokinesis. Mol Microbiol (2004) 0.86
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis (1986) 0.86
Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains. J Recept Signal Transduct Res (1999) 0.86
The effect of primary products of lipid peroxidation on the transmembrane transport of calcium ions. J Mol Cell Cardiol (1982) 0.86
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle. Biochem Biophys Res Commun (1992) 0.86
Taurine and electrical activity of the heart. Circ Res (1974) 0.86
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res (1992) 0.86
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A (1986) 0.86
Trapidil derivatives as potential antiatherosclerotic drugs. Arzneimittelforschung (1987) 0.86
Mesenchymal stem cells in tissue growth and repair. Acta Naturae (2011) 0.85
Red blood cell targeting to collagen-coated surfaces. FEBS Lett (1983) 0.85
Electron microscopy study of fibronectin structure. FEBS Lett (1980) 0.85
Further characterization of recessive suppression in yeast. Isolation of the low-temperature sensitive mutant of Saccharomyces cerevisiae defective in the assembly of 60 S ribosomal subunit. Biochim Biophys Acta (1981) 0.85
Localization of possible functional domains in sup2 gene product of the yeast Saccharomyces cerevisiae. FEBS Lett (1987) 0.85
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb (1991) 0.85
On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol (1985) 0.85
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Artery Dis (1993) 0.85
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content. Acta Anat (Basel) (1983) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
A structural study of filamin, a high-molecular-weight actin-binding protein from chicken gizzard. Eur J Biochem (1982) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
An electron microscopic histochemical investigation of the localization of creatine phosphokinase in heart cells. Biochim Biophys Acta (1977) 0.84
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84
A monoclonal antibody, VM64, reacts with a 130 kDa glycoprotein common to platelets and endothelial cells: heterogeneity in antibody binding to human aortic endothelial cells. Thromb Haemost (1991) 0.84
High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. FEBS Lett (1985) 0.84
The principles of enzyme stabilization. IV. Modification of 'key' functional groups in the tertiary structure of proteins. Biochim Biophys Acta (1979) 0.84
Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem (1986) 0.84